undamentalytics Newsletter

Brookner Mark J: insider trades

Director at U S Physical Therapy Inc. No open-market purchases and 27 sales not made under a pre-set plan, reported from December 6, 2010 to November 16, 2022.

What happened after Brookner Mark J’s sales?

After their sales, the shares moved −5.3% against the index over 12 months on average (a negative figure means selling was the right call); 63% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Brookner Mark J: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 27 +0.5% +1.6% 48% 9 0.89 0.40 No reliable evidence
Sales, 12 months after the report 27 −5.3% −4.2% 63% 9 0.23 0.83 No reliable evidence
Sales, 12 months after the trade 27 −3.9% −4.5% 59% 9 0.35 0.74 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
U S Physical Therapy Inc USPH —027December 6, 2010November 16, 2022

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 16, 2022November 15, 2022 USPH Sale $134,400 +16.2%−13.4%−11.7%
June 3, 2021June 2, 2021 USPH Sale $150,000 −8.7%−4.2%−5.4%
May 27, 2021May 26, 2021 USPH Sale $120,000 −6.6%−0.3%−1.4%
May 12, 2021May 11, 2021 USPH Sale $120,250 −12.1%−9.3%−9.3%
November 17, 2020November 16, 2020 USPH Sale $266,535 +18.0%−44.0%−40.3%
June 5, 2020June 5, 2020 USPH Sale $104,376 +1.6%+6.4%+3.5%
June 5, 2020June 3, 2020 USPH Sale $110,825 +1.6%+6.4%+18.2%
May 29, 2020May 28, 2020 USPH Sale $63,471 +6.7%+17.9%+17.1%
December 10, 2019December 6, 2019 USPH Sale $116,730 −7.8%−21.9%−25.8%
November 29, 2019November 26, 2019 USPH Sale $116,000 −2.6%−24.3%−24.4%
November 22, 2019November 21, 2019 USPH Sale $116,250 −4.8%−21.8%−24.7%
August 19, 2019August 15, 2019 USPH Sale $404,510 −23.6%−53.7%−53.5%
May 8, 2019May 7, 2019 USPH Sale $378,788 +11.7%−42.7%−42.2%
May 6, 2019May 3, 2019 USPH Sale $361,669 +5.7%−42.2%−36.9%
November 20, 2018November 16, 2018 USPH Sale $59,250 −9.7%−18.0%−17.1%
November 6, 2018November 5, 2018 USPH Sale $227,500 −5.3%−10.3%+15.3%
September 24, 2018September 21, 2018 USPH Sale $290,000 +1.9%+6.7%+10.2%
September 10, 2018September 7, 2018 USPH Sale $80,312 −1.9%0.0%+1.3%
August 24, 2018August 23, 2018 USPH Sale $511,081 +5.1%+11.1%+12.9%
May 17, 2018May 16, 2018 USPH Sale $114,788 +17.2%+22.1%+19.6%
December 28, 2017December 27, 2017 USPH Sale $186,990 +15.4%+47.4%+50.3%
September 9, 2014September 4, 2014 USPH Sale $111,157 +8.3%+28.5%+28.5%
September 3, 2014August 29, 2014 USPH Sale $23,097 +6.9%+28.5%+29.9%
June 1, 2011May 27, 2011 USPH Sale $288,706 −10.5%+1.6%−2.4%
May 26, 2011May 26, 2011 USPH Sale $249,000 −7.4%−2.4%−4.5%
December 16, 2010December 15, 2010 USPH Sale $39,750 +3.7%−4.6%−4.8%
December 6, 2010December 3, 2010 USPH Sale $18,043 −4.7%−6.8%−6.7%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Brookner Mark J traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.